| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
|
|
|
|
|||||||||||||
|
|
|||||||||||||||
Department of Cell Biology and Neuroscience, University of Texas Southwestern Medical Centre at Dallas 75235-9039, USA. Shay@utsw.swmed.edu
Although there is justifiable optimism regarding telomerase activity and early detection of cancer, it is important to point out that there is much that remains to be understood and additional validation studies will be required before knowledge of telomerase activity will be useful in decisions regarding patient management. A key question is whether we will be able to distinguish those cancers that are going to progress from those cancers that are not by detecting telomerase activity. Molecular staging using markers such as telomerase activity in combination with other molecular markers may be particularly useful in this regard. Basic scientists and clinicians must work together if this strategy is to mature. Telomerase inhibitors in the treatment of cancer are awaited with great anticipation.
This article has been cited by other articles:
|
|
 |
|
  M. A. Sanchini, R. Gunelli, O. Nanni, S. Bravaccini, C. Fabbri, A. Sermasi, E. Bercovich, A. Ravaioli, D. Amadori, and D. Calistri Relevance of Urine Telomerase in the Diagnosis of Bladder Cancer JAMA, October 26, 2005; 294(16): 2052 - 2056. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. I. Botchkina, R. H. Kim, I. L. Botchkina, A. Kirshenbaum, Z. Frischer, and H. L. Adler Noninvasive Detection of Prostate Cancer by Quantitative Analysis of Telomerase Activity Clin. Cancer Res., May 1, 2005; 11(9): 3243 - 3249. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. Jakupciak, W. Wang, P. E. Barker, S. Srivastava, and D. H. Atha Analytical Validation of Telomerase Activity for Cancer Early Detection: TRAP/PCR-CE and hTERT mRNA Quantification Assay for High-Throughput Screening of Tumor Cells J. Mol. Diagn., August 1, 2004; 6(3): 157 - 165. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. Ohali, S. Avigad, I.J. Cohen, I. Meller, Y. Kollender, J. Issakov, I. Gelernter, Y. Goshen, I. Yaniv, and R. Zaizov Association Between Telomerase Activity and Outcome in Patients With Nonmetastatic Ewing Family of Tumors J. Clin. Oncol., October 15, 2003; 21(20): 3836 - 3843. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Dikmen, E. Dikmen, M. Kara, E. Sahin, P. Dogan, and N. Ozdemir Diagnostic implications of telomerase activity in pleural effusions Eur. Respir. J., September 1, 2003; 22(3): 422 - 426. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Ikeda, H. Uemura, H. Ishiguro, M. Hori, M. Hosaka, S. Kyo, K.-i. Miyamoto, E. Takeda, and Y. Kubota Combination Treatment with 1{alpha},25-Dihydroxyvitamin D3 and 9-cis-Retinoic Acid Directly Inhibits Human Telomerase Reverse Transcriptase Transcription in Prostate Cancer Cells Mol. Cancer Ther., August 1, 2003; 2(8): 739 - 746. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Dikmen, M. Kara, G. Dikmen, H. Cakmak, and P. Dogan Detection of telomerase activity in bronchial lavage as an adjunct to cytological diagnosis in lung cancer Eur. J. Cardiothorac. Surg., February 1, 2003; 23(2): 194 - 199. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. W. Shay, Y. Zou, E. Hiyama, and W. E. Wright Telomerase and cancer Hum. Mol. Genet., April 1, 2001; 10(7): 677 - 685. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B.-S. Herbert, A. C. Wright, C. M. Passons, W. E. Wright, I. U. Ali, L. Kopelovich, and J. W. Shay Effects of Chemopreventive and Antitelomerase Agents on the Spontaneous Immortalization of Breast Epithelial Cells J Natl Cancer Inst, January 3, 2001; 93(1): 39 - 45. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Yan, J.-M. Coindre, J. Benhattar, F. T. Bosman, and L. Guillou Telomerase Activity and Human Telomerase Reverse Transcriptase mRNA Expression in Soft Tissue Tumors: Correlation with Grade, Histology, and Proliferative Activity Cancer Res., July 1, 1999; 59(13): 3166 - 3170. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. G. SAWANT, V. GREGOIRE, S. DHAR, C. B. UMBRICHT, S. CVILIC, S. SUKUMAR, and T. K. PANDITA Telomerase activity as a measure for monitoring radiocurability of tumor cells FASEB J, June 1, 1999; 13(9): 1047 - 1054. [Abstract] [Full Text]
|
|
|
|
|
|
J.-C. Soria, L. R. Gauthier, E. Raymond, C. Granotier, L. Morat, J.-P. Armand, F. D. Boussin, and L. Sabatier Molecular Detection of Telomerase-positive Circulating Epithelial Cells in Metastatic Breast Cancer Patients Clin. Cancer Res., May 1, 1999; 5(5): 971 - 975. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. W. Shay Toward Identifying a Cellular Determinant of Telomerase Repression J Natl Cancer Inst, January 6, 1999; 91(1): 4 - 6. [Full Text] [PDF]
|
|
|
|
|
|
M. Fossel Telomerase and the Aging Cell: Implications for Human Health JAMA, June 3, 1998; 279(21): 1732 - 1735. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
| Journal of Clinical Pathology | Molecular Pathology |
